Abstract:Introduction: The maintenance of intestinal homeostasis depends on a complex interaction between the immune system, intestinal epithelial barrier, and microbiota. Alteration in one of these components could lead to the development of inflammatory bowel diseases (IBD). Variants within the autophagy gene ATG16L1 have been implicated in susceptibility and severity of Crohn's disease (CD). Individuals carrying the risk ATG16L1 T300A variant have higher caspase 3-dependent degradation of ATG16L1 resulting in impaired autophagy and increased cellular stress. ATG16L1-deficiency induces enhanced IL-1β secretion in dendritic cells in response to bacterial infection. Infection of ATG16L1-deficient mice with a persistent strain of murine norovirus renders these mice highly susceptible to dextran sulfate sodium colitis. Moreover, persistent norovirus infection leads to intestinal virus specific CD8 + T cells responses. Both Toll-like receptor 7 (TLR7), which recognizes single-stranded RNA viruses, and ATG16L1, which facilitates the delivery of viral nucleic acids to the autolysosome endosome, are required for anti-viral immune responses. Results and discussion: However, the role of the enteric virome in IBD is still poorly understood. Here, we investigate the role of TLR7 and ATG16L1 in intestinal homeostasis and inflammation. At steady state, Tlr7 -/- mice have a significant increase in large intestinal lamina propria (LP) granzyme B + tissue-resident memory CD8 + T (T RM ) cells compared to WT mice, reminiscent of persistent norovirus infection. Deletion of Atg16l1 in myeloid ( Atg16l1 ΔLyz2 ) or dendritic cells ( Atg16l1 ΔCd11c ) leads to a similar increase of LP T RM . Furthermore, Tlr7 -/- and Atg16l1 ΔCd11c mice were more susceptible to dextran sulfate sodium colitis with an increase in disease activity index, histoscore, and increased secretion of IFN-γ and TNF-α. Treatment of Atg16l1 ΔCd11c mice with the TLR7 agonist Imiquimod attenuated colonic inflammation in these mice. Our data demonstrate that ATG16L1-deficiency in myeloid and dendritic cells leads to an increase in LP T RM and consequently to increased susceptibility to colitis by impairing the recognition of enteric viruses by TLR7. Conclusion: In conclusion, the convergence of ATG16L1 and TLR7 signaling pathways plays an important role in the immune response to intestinal viruses. Our data suggest that activation of the TLR7 signaling pathway could be an attractive therapeutic target for CD patients with ATG16L1 risk variants.

IFN-I and IL-22 mediate protective effects of intestinal viral infection

The intestinal regionalization of acute norovirus infection is regulated by the microbiota via bile acid-mediated priming of type III interferon

Intestinal tuft cell immune privilege enables norovirus persistence

Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling

Activation of Nod2 signaling upon norovirus infection enhances antiviral immunity and susceptibility to colitis

Interaction with mammalian enteric viruses alters outer membrane vesicle production and content by commensal bacteria

Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity

Commensal Microbiota Modulation of Natural Resistance to Virus Infection

Intestinal microbiota programming of alveolar macrophages influences severity of respiratory viral infection

Enteric viruses evoke broad host immune responses resembling bacterial microbiome

Toll-like receptor 7 protects against intestinal inflammation and restricts the development of colonic tissue-resident memory CD8+ T cells

A paradox of transcriptional and functional innate interferon responses of human intestinal enteroids to enteric virus infection

Intestinal Innate Antiviral Immunity and Immunobiotics: Beneficial Effects against Rotavirus Infection

The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis

The Intestinal Microbiome Primes Host Innate Immunity against Enteric Virus Systemic Infection through Type I Interferon

Bacterial extracellular vesicles control murine norovirus infection through modulation of antiviral immune responses

Immunomodulation by Enteric Viruses

Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections

IHNV Infection Induces Strong Mucosal Immunity and Changes of Microbiota in Trout Intestine

Interferons and tuft cell numbers are bottlenecks for persistent murine norovirus infection

RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury